Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("PROBUCOL")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 485

  • Page / 20

Export

Selection :

  • and

Probucol restores the defective leukocyte-endothelial interaction in experimental diabetesZANARDO, Renata C. O; CRUZ, José W. M. C; MARTINEZ, Luis L et al.European journal of pharmacology. 2003, Vol 478, Num 2-3, pp 211-219, issn 0014-2999, 9 p.Article

Anti-apoptotic effects of probucol are associated with downregulation of daxx expression in THP-1 macrophageBO SU; YANG, Yun-Bo; TUO, Qin-Hui et al.Cardiovascular drugs and therapy. 2007, Vol 21, Num 1, pp 37-45, issn 0920-3206, 9 p.Article

Viability of Developing CETP InhibitorsSIRTORI, Cesare R; MOMBELLI, Giuliana.Cardiovascular therapeutics (Print). 2008, Vol 26, Num 2, pp 135-146, issn 1755-5914, 12 p.Article

AGI-1067 : A novel vascular protectant for prevention of restenosisFRANKS, Amy M; GARDNER, Stephanie F.The Annals of pharmacotherapy. 2006, Vol 40, Num 1, pp 66-73, issn 1060-0280, 8 p.Article

Probucol inhibits ABCA1-mediated cellular lipid effluxFAVARI, Elda; ZANOTTI, Ilaria; ZIMETTI, Francesca et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 12, pp 2345-2350, issn 1079-5642, 6 p.Article

Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathwayYANG, Yun-Bo; YANG, Yi-Xin; BO SU et al.European journal of pharmacology. 2007, Vol 570, Num 1-3, pp 125-134, issn 0014-2999, 10 p.Article

EFFECT OF PROBUCOL ON THE ACTIVITY OF POTHEPARIN PLASMA LIPOPROTEIN LIPASE AND HEPATIC LIPASEMIETTINEN TA; HUTTUNEN JK; KUUSI T et al.1981; CLIN. CHIM. ACTA; ISSN 0009-8981; NLD; DA. 1981; VOL. 113; NO 1; PP. 59-64; BIBL. 25 REF.Article

SAFETY AND EFFICACY OF PROBUCOL DURING ONE YEAR OF ADMINISTRATION = L'INNOCUITE ET L'EFFICACITE DU PROBUCOL AU COURS D'UNE ANNEE D'ADMINISTRATIONNASH DT.1974; J. CLIN. PHARMACOL.; U.S.A.; DA. 1974; VOL. 14; NO 8-9; PP. 470-475; BIBL. 9REF.Article

LONG-TERM ORAL ADMINISTRATION OF PROBUCOL (4,4PRIME -(ISOPROPYLIDENEDITHIO) BIS (2,6-DI-T-BUTYLPHENOL)) (DH-581) IN THE MANAGEMENT OF HYPERCHOLESTEROLEMIA = ADMINISTRATION ORALE A LONG TERME DE PROBUCOL PENDANT LE TRAITEMENT DE L'HYPERCHOLESTEROLEMIEHARRIS RS JR; GILMORE HR III; BRICKER LA et al.1974; J. AMER. GERIATR. SOC.; U.S.A.; DA. 1974; VOL. 22; NO 4; PP. 167-175; BIBL. 13REF.Article

Influence of aging on gastric ulcer healing activities of the antioxidants α-tocopherol and probucolISHIHARA, Masashi; KOJIMA, Ryoji; ITO, Mikio et al.European journal of pharmacology. 2008, Vol 601, Num 1-3, pp 143-147, issn 0014-2999, 5 p.Article

Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activityJIANG, Jun-Lin; ZHANG, Xiao-Hong; LI, Nian-Sheng et al.Cardiovascular drugs and therapy. 2006, Vol 20, Num 4, pp 281-294, issn 0920-3206, 14 p.Article

SUBPOPULATIONS OF APOLIPOPROTEIN A-I IN HUMAN HIGH-DENSITY LIPOPROTEINS THEIR METABOLIC PROPERTIES AND RESPONSE TO DRUG THERAPYATMEH RF; SHEPHERD J; PACKARD CJ et al.1983; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1983; VOL. 751; NO 2; PP. 175-188; BIBL. 31 REF.Article

PROBUCOL. A NEW CHOLESTEROL LOWERING DRUGNASH DT.1975; J. MED.; U.S.A.; DA. 1975; VOL. 6; NO 5-6; PP. 305-315; BIBL. 3 REF.Article

Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbitsJEON, Seon-Min; BOK, Song-Hae; JANG, Moon-Kyoo et al.Clinica chimica acta. 2002, Vol 317, Num 1-2, pp 181-190, issn 0009-8981Article

Formation of malonaldehyde in the presence of probucol, an anti-atherosclerosis drugMIYAKE, T; SHIBAMOTO, T.Food and chemical toxicology. 1998, Vol 36, Num 9-10, pp 841-847, issn 0278-6915Article

Inhibition of Suicidal Erythrocyte Death by ProbucolSHAIK, Nazneen; LUPESCU, Adrian; LANG, Florian et al.Journal of cardiovascular pharmacology. 2013, Vol 61, Num 2, pp 120-126, issn 0160-2446, 7 p.Article

Probucol therapy improves long-term (>10-year) survival after complete revascularization: A propensity analysisKASAI, Takatoshi; MIYAUCHI, Katsumi; KUBOTA, Naozumi et al.Atherosclerosis. 2012, Vol 220, Num 2, pp 463-469, issn 0021-9150, 7 p.Article

Interplay Between Heme Oxygenase-1 and the Multifunctional Transcription Factor Yin Yang 1 in the Inhibition of Intimal HyperplasiaBECK, Konstanze; WU, Ben J; JUN NI et al.Circulation research. 2010, Vol 107, Num 12, pp 1490-1497, issn 0009-7330, 8 p.Article

Characterization and Physical Stability of Spray Dried Solid Dispersions of Probucol and PVP-K30THVBO, Pia; PEDERSEN, Betty L; HOVGAARD, Lars et al.Pharmaceutical development and technology. 2008, Vol 13, Num 5, pp 375-386, issn 1083-7450, 12 p.Article

Probucol, a hypocholesterolemic agent, prevents the development of uterine adenomyosis induced by pituitary grafting in miceZHOU, Ying-Fang; MORI, Takao; NAGASAWA, Hiroshi et al.Anticancer research. 2004, Vol 24, Num 4, pp 2209-2212, issn 0250-7005, 4 p.Article

Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in ratsSO YOUN PARK; JEONG HYUN LEE; CHI DAE KIM et al.Brain research. 2007, Vol 1157, pp 112-120, issn 0006-8993, 9 p.Article

THE ADDITIVE EFFECT OF PROBUCOL ON DIET IN HYPERLIPIDEMIA = L'EFFET ADDITIF DU PROBUCOL SUR LE REGIME DANS L'HYPERLIPIDEMIEBROWN HB; DEWOLFE VG.1974; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1974; VOL. 16; NO 1PART.1; PP. 44-50; BIBL. 13REF.Article

Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanismHIRANO, Ken-Ichi; IKEGAMI, Chiaki; UEDA, Yukihiko et al.Arteriosclerosis, thrombosis, and vascular biology. 2005, Vol 25, Num 11, pp 2422-2427, issn 1079-5642, 6 p.Article

Enzymatic characterization of lipid-based drug delivery systemsLJUSBERG-WAHREN, Helena; NIELSEN, Flemming Seier; BROGARD, Mattias et al.International journal of pharmaceutics. 2005, Vol 298, Num 2, pp 328-332, issn 0378-5173, 5 p.Conference Paper

Pravastatin has an additional depressor effect in patients undergoing long-term treatment with antihypertensive drugsIKEDA, Toshio; SAKURAI, Jun; NAKAYAMA, Daisuke et al.American journal of hypertension. 2004, Vol 17, Num 6, pp 502-506, issn 0895-7061, 5 p.Article

  • Page / 20